SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 68 filers reported holding SYNERON MEDICAL LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $274,000 | +15.6% | 32,671 | -1.4% | 0.00% | – |
| Q3 2016 | $237,000 | +15.6% | 33,147 | +24.0% | 0.00% | – |
| Q2 2016 | $205,000 | +3.0% | 26,721 | -1.8% | 0.00% | – |
| Q1 2016 | $199,000 | +21.3% | 27,197 | +27.9% | 0.00% | – |
| Q4 2015 | $164,000 | +11.6% | 21,264 | +3.4% | 0.00% | – |
| Q3 2015 | $147,000 | -30.3% | 20,568 | +3.5% | 0.00% | – |
| Q2 2015 | $211,000 | -1.4% | 19,872 | +15.1% | 0.00% | – |
| Q1 2015 | $214,000 | +40.8% | 17,270 | +6.1% | 0.00% | – |
| Q4 2014 | $152,000 | -1.9% | 16,270 | +5.4% | 0.00% | – |
| Q3 2014 | $155,000 | +3.3% | 15,436 | +5.9% | 0.00% | – |
| Q2 2014 | $150,000 | -17.1% | 14,578 | 0.0% | 0.00% | – |
| Q1 2014 | $181,000 | +13.8% | 14,578 | +12.7% | 0.00% | – |
| Q4 2013 | $159,000 | +60.6% | 12,940 | +12.6% | 0.00% | – |
| Q3 2013 | $99,000 | +11.2% | 11,488 | +11.9% | 0.00% | – |
| Q2 2013 | $89,000 | – | 10,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 706,107 | $5,931,000 | 5.46% |
| NORTH TIDE CAPITAL, LLC | 3,500,000 | $29,400,000 | 5.03% |
| Senvest Management, LLC | 3,777,775 | $31,733,000 | 2.26% |
| Kenmare Capital Partners, L.L.C. | 269,839 | $2,267,000 | 1.72% |
| Camber Capital Management LP | 2,347,593 | $19,720,000 | 1.03% |
| DALTON GREINER HARTMAN MAHER & CO | 1,785,826 | $15,001,000 | 0.88% |
| PERRITT CAPITAL MANAGEMENT INC | 425,170 | $3,571,000 | 0.87% |
| Profit Investment Management, LLC | 88,777 | $746,000 | 0.70% |
| DAFNA Capital Management LLC | 85,947 | $722,000 | 0.63% |
| Lapides Asset Management, LLC | 396,800 | $3,333,000 | 0.60% |